Last reviewed · How we verify
NCT05595967
Community Based Health Education for Prevention of Pelvic Floor Dysfunction in Fertile Women in Rural China
NA trial testing Health education intervention in Pelvic Floor Dysfunction in 1,139 participants. Status unknown.
30 July 2023
Quick facts
| Lead sponsor | Peking University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 1,139 |
| Start date | 18 August 2022 |
| Primary completion | 30 July 2023 |
| Estimated completion | 5 August 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Health education intervention
Conditions studied
- Pelvic Floor Dysfunction — all drugs for Pelvic Floor Dysfunction →
Sponsor
Peking University
Who can join
Adults 18 to 65, female only, with Pelvic Floor Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
According to the experts in charge of the healthcare department in the Liangshan area, Liangshan is one of the largest Yi inhabited areas in China. Influenced by local culture and production history, most women there are multiparas, with more than one child, and their awareness of postpartum recovery is relatively weak. Therefore, the prevalence and incidence rate of pelvic floor dysfunction diseases is high in the Liangshan area. In addition, women in the Liangshan area shoulder the responsibility of taking care of family members, farmland, and livestock. They play an important role in family production, which guarantees the opportunity for other family members to go out to work. However, pelvic floor dysfunction can be manifested by persistent pelvic distension, frequent urination, the urgency of urination, difficulty in urination or defecation, and pain or difficulty in sexual intercourse, which decreases the quality of normal life, and the efficiency of production, posing many psychological problems and family contradictions. There is no research to prove the exact intervention measures that can effectively improve the pelvic floor function of women in Liangshan ethnic minority areas. This study aims to promote the formation of women's healthy living habits and behaviors, improve women's pelvic floor function, and then develop the quality of life and labor output of local women through intervention including health knowledge education and pelvic floor muscle exercise.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05595967
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Health education intervention
Trials testing the same drug.
- NCT06424847 — Effects of a Lifestyle and Sleep Intervention in Non-exercising Adults · NA · recruiting
Other recruiting trials for Pelvic Floor Dysfunction
Currently open trials in the same condition.
- NCT06924450 — Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery · NA · recruiting
- NCT07094698 — Sacral Stimulation in Women With Low Back Pain: Effects on Pelvic Functions and Daily Life · NA · active not recruiting
- NCT06777134 — Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients · recruiting
- NCT06677541 — Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients · NA · recruiting
- NCT07180524 — Prospective Clinical Trial on the Impact of Uterine Firomatosis on Pelvic Floor. · recruiting
Other Peking University trials
Trials by the same sponsor.
- NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
- NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
- NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
- NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
- NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05595967 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University
- Last refreshed: 1 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05595967.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing